1. Mesenchymal stem cell-derived exosomes: therapeutic implications for rotator cuff injury
- Author
-
Jinbing He, Shuai Ping, Xi Yuan, Fangyang Yu, Jun Qi, and Jiang Wang
- Subjects
0301 basic medicine ,Embryology ,Angiogenesis ,Biomedical Engineering ,Exosomes ,Bioinformatics ,Rotator Cuff Injuries ,Tendons ,Rotator Cuff ,03 medical and health sciences ,Paracrine signalling ,0302 clinical medicine ,medicine ,Animals ,Rotator cuff ,business.industry ,Rotator cuff injury ,Mesenchymal stem cell ,Mesenchymal Stem Cells ,medicine.disease ,Microvesicles ,Tendon ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Shoulder joint ,business - Abstract
Rotator cuff injuries are a common clinical condition of the shoulder joint. Surgery that involves reattaching the torn tendon to its humeral head bony attachment has a somewhat lower success rate. The scar tissue formed during healing of the rotator cuff leads to poor tendon-related mechanical properties. To promote healing, a range of genetic interventions, as well as cell transplantation, and many other techniques have been explored. In recent years, the therapeutic promise of mesenchymal stem cells (MSCs) has been well documented in animal and clinical studies. Some data have suggested that MSCs can promote angiogenesis, reduce inflammation and cell proliferation and increase collagen deposition. These functions are likely paracrine effects of MSCs, particularly mediated through exosomes. Here, we review the use of MSCs-related exosomes in tissues and organs. We also discuss their potential utility for treating rotator cuff injuries, and explore the underlying mechanisms of their effects.
- Published
- 2021